Skip to main content
GRFS logo
GRFS
(NASDAQ)
Grifols, S.A.
$8.24-- (--)
Loading... - Market loading

Grifols (GRFS) Stock Price & Financial Analysis

Grifols Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.00 - $8.25
52-Week High$11.14
52-Week Low$6.19
Open$8.13
Volume758.49K
Average Volume (3M)758.49K
Market Cap5.61B
Shares Outstanding680.58M
P/E Ratio (TTM)12.14
Forward P/E6.07
Price to Sales (P/S)0.65
Price to Book (P/B)0.92
EV/EBITDA7.96
Revenue (TTM)8.65B
Net Income (TTM)462.09M
Free Cash Flow (TTM)890.35M
EPS (TTM)$0.68
Profit Margin5.34%
Operating Margin16.97%
Return on Equity (ROE)7.61%
Debt to Equity1.66
50-Day MA$8.72
200-Day MA$9.28
52-Week Change18.53%
Annual Dividend$0.17
Dividend Yield2.10%
Payout Ratio25.45%
Last Dividend Ex-DateAug 20, 2026

Frequently Asked Questions About Grifols

What is the current stock price for GRFS?

As of the latest trading session, GRFS stock trades at $8.24. The 52-week range is $6.19–$11.14, with a day range of $8.00–$8.25.

What is the P/E ratio for GRFS?

Grifols's trailing P/E ratio is 12.1, meaning investors pay $12.1 for every $1 of annual earnings. The forward P/E is 6.1, reflecting analyst expectations for future earnings. Grifols operates in the Healthcare sector.

Does GRFS pay dividends?

Yes, Grifols pays a 2.10% annual dividend yield ($0.17 per share). The payout ratio is 25.4%. The last ex-dividend date was 2026-08-20.

What do analysts recommend for GRFS?

Analyst ratings and recommendations for GRFS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GRFS?

Grifols's market capitalization is $5.61B, classifying it as a mid-cap company. Grifols operates in the Healthcare sector within the Drug Manufacturers - General industry.